Straumann Holding AG (OTCMKTS:SAUHY) Sees Large Increase in Short Interest

Straumann Holding AG (OTCMKTS:SAUHY) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totaling 44,911 shares, a growth of 669.4% from the September 15th total of 5,837 shares. Based on an average daily volume of 130,960 shares, the short-interest ratio is currently 0.3 days. Approximately 0.0% of the company’s shares are short sold.

Straumann Stock Up 2.5%

Straumann stock traded up $0.26 during trading hours on Friday, hitting $10.76. The company had a trading volume of 136,860 shares, compared to its average volume of 78,702. The firm’s fifty day moving average is $11.72 and its 200-day moving average is $11.66. Straumann has a fifty-two week low of $9.44 and a fifty-two week high of $13.61.

Analysts Set New Price Targets

SAUHY has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft downgraded shares of Straumann from a “buy” rating to a “hold” rating in a research note on Friday, August 21st. Berenberg Bank upgraded Straumann to a “strong-buy” rating in a report on Thursday, September 17th. The Goldman Sachs Group raised Straumann from a “neutral” rating to a “buy” rating in a research report on Monday, September 14th. Barclays reissued an “overweight” rating on shares of Straumann in a research note on Thursday, June 18th. Finally, UBS Group upgraded Straumann from a “neutral” rating to a “buy” rating in a research report on Tuesday, September 1st. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Straumann Company Profile

Straumann Group is a Swiss company focused on implant, restorative and orthodontic dentistry. The company develops, manufactures and distributes dental implants, prosthetic components, instruments and related solutions used by dental professionals and laboratories.

Its portfolio also includes biomaterials for tissue regeneration, digital dentistry technologies and intraoral scanning solutions, as well as clear aligners offered through its ClearCorrect business. Straumann provides products and services intended to support dental restoration, tooth replacement, orthodontic treatment and digital treatment planning.

Founded in 1954 and headquartered in Basel, Switzerland, Straumann serves dental professionals, laboratories and patients through operations and distribution networks across numerous markets worldwide.